- Always ≥99% purity
- Manufactured and sealed in a sterile environment
- Up to 70% more active ingredient than the market average
- Each batch is double-tested by an independent laboratory
SAFETY DATA SHEET
MK-677 HPLC BA34001
MK-677 COA BA34001
Core learning : What you need to know about MK677
Ibutamoren, also known as MK-677, is an orally active, long-acting growth hormone secretagogue that mimics the action of ghrelin by binding to the ghrelin receptor (GHS-R1a) in the brain. This results in a sustained, dose-dependent increase in circulating growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels without significantly affecting cortisol or prolactin secretion. Unlike recombinant GH administration, MK-677 stimulates natural pulsatile release of growth hormone, which may preserve physiological feedback mechanisms and receptor sensitivity.
In clinical and experimental settings, MK-677 has demonstrated the ability to:
Ibutamoren’s oral bioavailability, extended half-life, and minimal suppression of endogenous hormone production make it an attractive candidate for long-term research into GH-related therapies, sarcopenia, and age-associated decline in anabolic hormones.
CAS Number: 159752-10-0
Molecular formula: C27H36N4O5S
Molar mass: 528.7 g/mol
Purity: ≥99% (see HPLC and COA documentation)
Concentration: 10 mg
Half-life: ~24 hours
Storage: 2 years at 20°C
⚠ Important Note: This product is supplied strictly for laboratory research use only. It is not approved for human consumption or therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease.
A non-peptide growth hormone secretagogue used in investigational studies on GH axis modulation, aging, and muscle wasting.
MK-677, not to be confused with MK-2866 (Ostarine) also known by its research code Ibutamoren mesylate, is a selective, orally active growth hormone secretagogue (GHS). It is not a SARM (Selective Androgen Receptor Modulator) but is frequently grouped with them due to its presence in performance-enhancement and metabolic studies.

MK-677 functions as a ghrelin receptor agonist — specifically targeting the GHS-R1a (Growth Hormone Secretagogue Receptor 1a) located in the hypothalamus and pituitary.
Once bound:
“In contrast to exogenous GH, MK-677 stimulates physiological GH release, preserving hypothalamic–pituitary signaling.”
— Murphy et al., J Clin Endocrinol Metab, 1998
| Study Domain | Findings |
|---|---|
| GH/IGF-1 axis | Increases GH and IGF-1 levels dose-dependently (e.g., 1–3 mg/kg) |
| Body composition | Promotes lean body mass retention and slight fat loss in clinical studies |
| Muscle preservation | Shown to mitigate age-related sarcopenia and improve muscle strength |
| Bone density | May enhance bone turnover markers via IGF-1 activity |
| Sleep studies | Improves REM sleep duration and sleep quality metrics |
“MK-677 is a promising compound for long-term GH/IGF-1 modulation, but requires careful metabolic monitoring in trial models.”
— Smith et al., Growth Horm IGF Res, 2000
| Form | Oral suspension / powder (research-grade) |
|---|---|
| Dose Range (animal/lab) | 5–25 mg/day depending on model size and metabolism |
| Study Duration | 2–12 weeks in preclinical and human studies |
| Detection Method | LC-MS/MS for plasma analysis; GH and IGF-1 serum assays |
Read our articles:
https://maxmusclelabs.com/your-guide-to-mk-677/
https://maxmusclelabs.com/mk677-side-effects/
https://maxmusclelabs.com/checking-the-research-on-mk-677/
| Delivery - UK | Next working day |
|---|---|
| Delivery - Worldwide | 3-5 working days |
| Stock levels | Low |
| CAS Number | 159752-10-0 |
| Molecular formula | C27H36N4O5S |
| Molar mass | 528.7 g/mol |
| Purity | ≥99% (see HPLC and COA documentation) |
| Concentration | 10 mg |
| Half-life | ~24 hours |
| Storage | 2 years at 20°C |
There are no reviews yet.